Skip to main content
Premium Trial:

Request an Annual Quote

Christopher Kroeger, Bjorn Bontin, Len Hendrickson, Robert Weltman, Rajiv Doshi, Mary Jane Cunningham, Perry Karsen


Christopher Kroeger joined The Aurora Funds of Research Triangle Park, NC, as a life science associate. Kroeger holds a 2003 MBA from Harvard Business School, has a 1996 MD from Stanford and a BA in biology from Harvard. Previously, he was an associate in corporate development at Genzyme. He also spent four years as a general surgery resident at Brigham and Women’s Hospital; performed post-doctoral research at the Massachusetts Institute of Technology; and taught biology and chemistry at Caterham School, a private boarding academy in England.

Bjorn Bontin joins Gyros of Uppsala Science Park, Sweden, as chief financial officer, the company said last week. Bontin previously was CFO and investor relations manager for IBS. Mathias Branhammer, Gyros’s former vice president for finance and administration moves to the position of administration director of the company.

Len Hendrickson, president and chief executive officer of BioSource International, has taken an indefinite medical disability leave of absence, the company said last week. Robert Weltman, a director of the company, will serve as interim CEO as the firm begins a search for a replacement. Weltman is managing director of the private equity firm Genstar Capital. He holds an AB in chemistry from Princeton University.

Rajiv Doshi, a medical doctor and lecturer at Stanford University’s Department of Medicine, has joined Menlo Park, Calif.-based De Novo Ventures as a principal. Doshi holds a BS in chemical engineering, an MSE in biomechanical engineering, and an MD degree — all from Stanford University.

Mary Jane Cunningham has been appointed associate director of life sciences & health at the Houston Advanced Research Center, a non-profit organization designed to apply principles of sustainable development in Texas, the center said Sept. 5. Cunningham comes to HARC from Molecular Mining of Kingston, Ontario, where she was director of discoveries.

Perry Karsen joins Human Genome Sciences as senior vice president of business development. Karsen previously was general partner at New York-based Pequot Ventures. Prior to that, Karsen served in marketing and business development positions at Bristol-Myers Squibb from 1995 to 2000.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.